Bunge Global SA BG
97.97 USD +3.25 (+3.43%)
Nov 4, 2026, 2:23 PM EST
95.76 Day range 98.83
88.55 52-week range 131.41
- YTD
- +9.97%
- 1 year
- +4.33%
Analyst view
Consensus: buy
Buy
Price target (mean) 139.22 +42.1% upside
Now 97.97
- Target (low)
- 116.00
- Target (mean)
- 139.22
- Target (high)
- 155.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
- Strong buy3
- Buy5
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 3.19 | 3.12 – 3.37 | 1.99 | +60.5% | 25.32B | +6.6% | 7 |
| Next quarter | 2.39 | 2.14 – 2.62 | 1.83 | +30.5% | 21.86B | 0.0% | 4 |
| Current year | 9.44 | 8.86 – 9.75 | 7.57 | +24.7% | 94.05B | +33.7% | 8 |
| Next year | 11.00 | 9.92 – 11.75 | 9.44 | +16.5% | 95.88B | +1.9% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 10, 2026 | UBS | Maintained | Buy | Buy |
| Apr 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 1, 2026 | Barclays | Maintained | Overweight | Overweight |
| Mar 24, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 11, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Feb 5, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Feb 5, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 5, 2026 | UBS | Maintained | Buy | Buy |
| Feb 5, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jan 21, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Dec 16, 2025 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Dec 2, 2025 | B of A Securities | Maintained | Buy | Buy |
| Nov 6, 2025 | Barclays | Upgrade | Equal-Weight | Overweight |
| Oct 21, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 17, 2025 | Stephens & Co. | Maintained | Overweight | Overweight |
| Oct 16, 2025 | BMO Capital | Maintained | Outperform | Outperform |
| Oct 16, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 12, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2025 | Stephens & Co. | Maintained | Overweight | Overweight |
| Apr 15, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Feb 11, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Feb 11, 2025 | B of A Securities | Maintained | Buy | Buy |
| Feb 6, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jan 21, 2025 | Barclays | Downgrade | Overweight | Equal-Weight |
| Aug 1, 2024 | Citigroup | Downgrade | Buy | Neutral |
| Apr 25, 2024 | Citigroup | Maintained | Buy | Buy |
| Apr 3, 2024 | Citigroup | Maintained | Buy | Buy |
| Feb 13, 2024 | Goldman Sachs | Maintained | Buy | Buy |
